Wells Fargo’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$618M Buy
7,904,930
+390,152
+5% +$31.5M 0.1% 180
2026
Q1
$651M Buy
7,514,778
+475,411
+7% +$45.5M 0.12% 161
2025
Q4
$676M Buy
7,039,367
+106,488
+2% +$10.3M 0.12% 155
2025
Q3
$660M Buy
6,932,879
+65,802
+1% +$6.05M 0.13% 154
2025
Q2
$599M Sell
6,867,077
-25,027
-0.4% -$2.12M 0.12% 159
2025
Q1
$619M Buy
6,892,104
+159,933
+2% +$14.3M 0.14% 147
2024
Q4
$538M Sell
6,732,171
-281,008
-4% -$24.3M 0.12% 162
2024
Q3
$631M Sell
7,013,179
-197,918
-3% -$16.6M 0.14% 141
2024
Q2
$568M Sell
7,211,097
-685,355
-9% -$56.2M 0.14% 151
2024
Q1
$688M Sell
7,896,452
-5,155,494
-39% -$440M 0.17% 121
2023
Q4
$1.08B Sell
13,051,946
-701,370
-5% -$53.5M 0.28% 81
2023
Q3
$1.08B Sell
13,753,316
-56,931
-0.4% -$4.77M 0.32% 75
2023
Q2
$1.22B Buy
13,810,247
+4,471
+0% +$385K 0.34% 75
2023
Q1
$1.11B Buy
13,805,776
+945,090
+7% +$77M 0.32% 74
2022
Q4
$1,000M Sell
12,860,686
-372,082
-3% -$30.2M 0.3% 84
2022
Q3
$1.07B Sell
13,232,768
-261,456
-2% -$23.5M 0.35% 68
2022
Q2
$1.21B Sell
13,494,224
-1,076,152
-7% -$109M 0.37% 62
2022
Q1
$1.62B Buy
14,570,376
+942,334
+7% +$99.6M 0.41% 49
2021
Q4
$1.41B Sell
13,628,042
-1,139,020
-8% -$132M 0.35% 60
2021
Q3
$1.85B Buy
14,767,062
+139,316
+1% +$18M 0.41% 41
2021
Q2
$1.82B Sell
14,627,746
-659,672
-4% -$82.8M 0.4% 40
2021
Q1
$1.81B Sell
15,287,418
-172,558
-1% -$20.2M 0.41% 40
2020
Q4
$1.81B Buy
15,459,976
+473,712
+3% +$52.1M 0.44% 38
2020
Q3
$1.56B Buy
14,986,264
+74,368
+0.5% +$7.47M 0.43% 40
2020
Q2
$1.37B Buy
14,911,896
+684,910
+5% +$65.7M 0.4% 43
2020
Q1
$1.28B Buy
14,226,986
+336,914
+2% +$35.8M 0.44% 39
2019
Q4
$1.58B Sell
13,890,072
-42,662
-0.3% -$4.68M 0.42% 45
2019
Q3
$1.51B Sell
13,932,734
-417,762
-3% -$43.6M 0.43% 41
2019
Q2
$1.4B Buy
14,350,496
+635,871
+5% +$58.1M 0.4% 41
2019
Q1
$1.25B Buy
13,714,625
+291,291
+2% +$26.1M 0.37% 47
2018
Q4
$1.22B Buy
13,423,334
+724,279
+6% +$67.7M 0.41% 44
2018
Q3
$1.25B Sell
12,699,055
-784,357
-6% -$72.5M 0.35% 48
2018
Q2
$1.15B Sell
13,483,412
-458,488
-3% -$38.3M 0.34% 51
2018
Q1
$1.12B Buy
13,941,900
+782,123
+6% +$64.5M 0.33% 55
2017
Q4
$1.06B Buy
13,159,777
+781,446
+6% +$62.6M 0.31% 66
2017
Q3
$963M Buy
12,378,331
+165,149
+1% +$13.7M 0.3% 68
2017
Q2
$1.08B Buy
12,213,182
+280,610
+2% +$23.7M 0.35% 51
2017
Q1
$961M Buy
11,932,572
+1,895,386
+19% +$148M 0.31% 56
2016
Q4
$715M Sell
10,037,186
-2,535,248
-20% -$199M 0.25% 90
2016
Q3
$1.09B Sell
12,572,434
-1,029,288
-8% -$89.7M 0.4% 41
2016
Q2
$1.18B Sell
13,601,722
-29,062
-0.2% -$2.35M 0.46% 33
2016
Q1
$1.02B Buy
13,630,784
+520,590
+4% +$39.2M 0.41% 39
2015
Q4
$1.01B Buy
13,110,194
+253,096
+2% +$19.1M 0.4% 40
2015
Q3
$861M Buy
12,857,098
+459,401
+4% +$33.8M 0.36% 48
2015
Q2
$919M Buy
12,397,697
+542,021
+5% +$41.4M 0.35% 45
2015
Q1
$925M Buy
11,855,676
+3,569,015
+43% +$271M 0.36% 45
2014
Q4
$598M Buy
8,286,661
+37,429
+0.5% +$2.6M 0.23% 97
2014
Q3
$511M Buy
8,249,232
+122,972
+2% +$7.82M 0.21% 106
2014
Q2
$518M Buy
8,126,260
+306,605
+4% +$18.6M 0.21% 100
2014
Q1
$481M Sell
7,819,655
-332,588
-4% -$19.4M 0.2% 115
2013
Q4
$468M Buy
8,152,243
+351,361
+5% +$19.9M 0.2% 117
2013
Q3
$415M Buy
7,800,882
+303,150
+4% +$16.3M 0.2% 127
2013
Q2
$386M Buy
+7,497,732
New +$371M 0.2% 121

Other funds holding MDT

Wells Fargo's MDT Position: Q2 2026 in Review

Wells Fargo increased its Medtronic (MDT) stake by 5.2% in Q2 2026, buying an estimated $31.5M and bringing the position to 7,904,930 shares worth $618M. The position accounts for 0.1% of the portfolio, ranked #180.

Wells Fargo first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.85B in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wells Fargo held 7,904,930 shares of Medtronic worth $618M as of Q2 2026.
  • Wells Fargo bought 390,152 Medtronic shares in Q2 2026, an estimated $31.5M.
  • Medtronic made up 0.1% of Wells Fargo's portfolio in Q2 2026, its #180 holding.
  • Wells Fargo first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Medtronic position peaked at $1.85B in Q3 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.